BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15735580)

  • 1. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.
    Cunnick GH; Mokbel K
    Int J Fertil Womens Med; 2004; 49(5):237-8. PubMed ID: 15633483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials.
    Petrelli F; Barni S
    Radiother Oncol; 2011 Aug; 100(2):195-9. PubMed ID: 21411161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards optimal management of ductal carcinoma in situ of the breast.
    Mokbel K
    Eur J Surg Oncol; 2003 Mar; 29(2):191-7. PubMed ID: 12633565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.
    Viani GA; Stefano EJ; Afonso SL; De Fendi LI; Soares FV; Leon PG; GuimarĂ£es FS
    Radiat Oncol; 2007 Aug; 2():28. PubMed ID: 17683529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sentinel node biopsy necessary in conservatively treated DCIS?
    Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N
    Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH; Farley DR; Peros G
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in-situ: an update for clinical practice.
    Patani N; Khaled Y; Al Reefy S; Mokbel K
    Surg Oncol; 2011 Mar; 20(1):e23-31. PubMed ID: 21106367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen in ductal carcinoma in situ.
    Daly MB
    Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An argument against routine use of radiotherapy for ductal carcinoma in situ.
    Silverstein MJ
    Oncology (Williston Park); 2003 Nov; 17(11):1511-33; discussion 1533-4, 1539, 1542 passim. PubMed ID: 14682107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.